GL1X · GenesisL1 explorer

Research workbench

Crystal structure of hepatitis C virus polymerase in complex with an allosteric inhibitor (compound 1)

Analyse Crystal structure of hepatitis C virus polymerase in complex with an allosteric… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2BRK
Type
protein
Length
512 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
CMF, MN
Pockets
10 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein51250% helix, 16% strandP26663

Ligands and binding sites

  • CMF · 3-cyclohexyl-1-(2-morpholin-4-yl-2-oxoethyl)-2-phenyl-1H-indole-6-carboxylic acid · ligand · chains A
  • MN · Manganese (II) ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17340.720.7869MN
21890.500.7724empty
31080.450.7820CMF
4810.400.7814empty
5770.370.7718empty

Compared structures

  • 2BRK · Crystal structure of Hepatitis C virus polymerase in complex with an allosteric inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.